Pitavastatin Calcium

CAS: 147526-32-7

Ref. TR-P531000

Produktinformation

• Name: Pitavastatin Calcium
• Synonyme: (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium Salt (2:1), 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), [S-[R*,S*-(E)]]-, (E)-(3R,5S)-7-[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid hemicalcium salt, Flovas, Livalo, NK 104, NK 104 (acid), Pitava, Pitava 1, Pitavastatin hemicalcium, (+)-Monocalciumbis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-,5-dihydroxy-6-heptenoate}, (+)-Monocalciumbis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}, 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E)-, 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt (2:1), [S-[R*,S*-(E)]]-, Calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate, Nk 104, calcium bis{(1R,3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-1,3,5-trihydroxyhept-6-en-1-olate}

Beschreibung

Stability Hygroscopic
Applications A competitive inhibitor of HMG-CoA reductase. Antilipemic.
References Aoki, T., et al.: Arzneim.-Forsch., 47, 904 (1997), Yamada, I., et al.: Xenobiotica, 33, 789 (2003), Park, S., et al.: Clin. Ther., 27, 1074 (2005),

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 880.98
• Formel: C₂₅H₂₃FNO₄·Ca
• Farbe/Form: White To Off-White
• InChl: InChI=1S/2C25H24FNO4.Ca/c2*26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31, +2/p-2/b2*12-11+, , /q, /h2*1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31), /t2*18-,19-, /m11./s1
• InChI Key: InChIKey=LPPJGTSPIBSYQO-OVPLYUBASA-N
• SMILES: CC(=O)N[C@H](CS/C(Cl)=C/Cl)C(=O)O